![]() |
市场调查报告书
商品编码
1403384
全球医学高光谱影像市场预测(-2030):按产品、技术、应用、最终用户和地区分析Medical Hyperspectral Imaging Market Forecasts to 2030 - Global Analysis By Product, Technology, Application, End User and By Geography |
2023年全球医学高光谱影像市场规模将达18亿美元,预计2030年将达49亿美元,预测期内复合年增长率为15.1%。
高光谱影像(HSI)是一种新开发的医学影像技术,特别适用于影像导引手术和疾病辨识。 HSI获得了具有两个空间维度和一个频谱维度的超立方体资料集。透过空间分辨频谱成像,HSI 提供有关组织生理学、形状和成分的诊断资讯。
根据国际癌症研究机构(IARC)的数据,2020年报告了超过190万例大肠新病例,93万人死亡。预计到 2040 年,这一统计数字以年度为基础将分别成长 63%(320 万人)和 73%(160 万人)。
癌症盛行率上升
医学高光谱影像的主要应用之一是固态肿瘤的检测。癌症诊断的非侵入性、消除组织切片检查以及提供即时的显影剂诊断特征是与高光谱影像相关的一些主要优点。此外,由于癌症发生率上升刺激了对医学高光谱影像的需求不断增加,高光谱影像市场也在不断增长。
医疗高光谱影像系统的成本过高
高光谱遥测影像系统的成本包括高光谱遥测相机、光源、软体、反射面板、显微镜和其他配件的价格。然而,高光谱遥测相机和显微镜的成本限制了卫生系统在既定预算内提供治疗的能力。例如,高光谱遥测相机由中国Optosky生产,价格从45,000美元到48,800美元不等。在美国,该计划的起价通常为 50,000 美元。
越来越多的研究探索医疗应用
由于高光谱遥测系统仍处于探索医学应用的阶段,因此正在针对疾病诊断进行大量研究。根据 2023 年 1 月 NCBI 的研究报告,高光谱遥测影像可用于预测糖尿病足溃疡的癒合速度。根据这项研究的结果,高光谱遥测影像是一种廉价的测试,可以轻鬆纳入常规临床实践,并可能为糖尿病足溃疡的癒合潜力提供重要的见解。
大规模资料存储
资料的复杂性需要大量的储存空间,限制了市场的扩展,对于企业来说并不便宜。例如,根据 2022 年 4 月 Hindawi 的一篇论文,大量资料储存为与机器学习和深度学习相结合的高光谱遥测影像系统带来了很高的空间复杂性。然而,由于需要测试和学习大量的 HSI 原始资料,因此非常耗时。这将限制整个预测期内的市场成长。
自2019年12月爆发以来,疫情已蔓延至全球超过213个国家,世界卫生组织于2020年3月宣布进入公共卫生紧急状态。 COVID-19大流行导緻美国、中国、日本、印度和德国等主要国家长期封锁,导致非关键产品的製造设施关闭。结果,世界各地大多数工业设施被迫关闭或停止生产。
预计相机行业在预测期内将是最大的
相机行业占据最大份额,因为成像设备对于改善治疗方法和诊断准确性至关重要。由于高光谱遥测相机可以记录的波长范围很广,因此可以详细分析生物组织并改善疾病的检测。此外,高光谱影像在即时组织识别、疾病检测和手术指导等应用中的越来越多的使用也促进了需求的成长。这些相机为医疗专业人员提供了对组织成分的独特见解,有助于早期检测和治疗计划。
预计眼科在预测期内复合年增长率最高
由于医学高光谱影像具有改变眼科诊断的特殊能力,预计眼科产业将实现获利成长。眼科医学高光谱影像可以全面了解视网膜组织,并且能够准确诊断各种眼科疾病,例如老龄化黄斑部病变和糖尿病视网膜病变。此外,这种从眼组织提取频谱资讯的技术可以帮助早期诊断异常,并为客製化治疗提供有用的资讯。
由于医学的进步和技术应用的增加,亚太地区占据了最大的份额。该地区不断增长的人口和不断增加的医疗基础设施投资正在推动对最新医学成像技术的需求。高光谱影像能够提供广泛的频谱资讯,以提高疾病诊断和外科手术的准确性,这与该地区对尖端医疗技术的日益关注不谋而合。此外,癌症和心血管疾病等慢性疾病的流行增加了对尖端诊断工具的需求,而高光谱遥测影像提供了突破性的治疗方法。
由于政府努力支持中国、印度和日本等国家的医疗基础设施和研究能力,预计亚太地区将保持良好的成长。该地区强大的研究社群以及学术机构和产业相关人员之间的合作不断推动创新。此外,医疗专业人员对高光谱影像在眼科、皮肤科和肿瘤学等广泛医疗应用中的优势的专业知识不断增长,也推动了高光谱成像的广泛接受。
According to Stratistics MRC, the Global Medical Hyperspectral Imaging Market is accounted for $1.8 billion in 2023 and is expected to reach $4.9 billion by 2030 growing at a CAGR of 15.1% during the forecast period. Hyperspectral imaging (HSI), a newly developed imaging method used in medicine, is especially useful for image-guided surgery and the identification of illnesses. The hypercube dataset, which has two spatial dimensions and one spectral dimension, is acquired through HSI. Through spatially resolved spectrum imaging, HSI provides diagnostic information on tissue physiology, shape, and composition.
According to the International Agency for Research on Cancer (IARC), in 2020, more than 1.9 million new cases of colorectal were reported leading to 930,000 deaths. The mentioned statistics are predicted to increase by 63% (3.2 million new cases) and 73% (1.6 million), respectively, by 2040 on an annual basis.
One of the main uses of medical hyperspectral imaging is solid tumor detection. The non-invasive nature of cancer diagnosis, the omission of tissue biopsies, and the provision of diagnostic signatures without the requirement for a real-time contrast agent are some of the primary benefits linked to hyperspectral imaging. Furthermore, the market is growing as a result of the rising demand for medical hyperspectral imaging spurred on by the rising incidence of cancer.
The price of the hyperspectral camera, light sources, software, reflectance panel, microscope, and additional accessories have been included in the cost of a hyperspectral imaging system. However, the expense of hyperspectral cameras and microscopes strains the healthcare system's ability to provide treatment within the allotted budget. For instance, hyperspectral cameras are produced by the Chinese business Optosky, and they cost between $45,000 and $48,800. This method frequently begins at USD 50,000 and rises upwards in the US.
As hyperspectral systems are still in their exploratory stages of usage in medicine, many studies are being conducted to diagnose diseases. A January 2023 NCBI research report states that hyperspectral imaging can be used to forecast the rate at which diabetic foot ulcers will heal. According to the study's results, hyperspectral imaging is an inexpensive test that can be readily included in regular clinical practice and may offer significant insights into DFU's capacity to heal.
Due to the complexity of data, large storage areas are required, which limits market expansion and is not inexpensive for businesses. For instance, bulk data storage causes high space complexity for hyperspectral imaging systems combined with machine and deep learning, according to a Hindawi paper from April 2022. However, it takes a long time because of the massive amount of raw HSI data that needs to be tested and trained. This restricts market growth throughout the projection period.
The World Health Organization declared the disease a public health emergency in March 2020 after it spread to over 213 nations worldwide since the outbreak in December 2019. The COVID-19 pandemic resulted in a protracted lockdown in major nations such as the United States, China, Japan, India, and Germany, which led to the suspension of manufacturing facilities that do not correspond to critical products. It caused the majority of industrial facilities worldwide to either close or halt their production.
Because imaging instruments are essential for improving therapeutic treatments and diagnostic accuracy, the cameras portion held the largest share. The wide range of wavelengths that hyperspectral cameras can record enables it feasible to analyze biological tissues in enormous detail and improve the detection of disorders. Additionally, the growing use of hyperspectral imaging for applications like real-time tissue distinction, illness detection, and surgical guidance is contributing to the demand increase. These cameras help with early detection and treatment planning by providing healthcare professionals with unique insights into tissue composition.
Because of the special powers of medical hyperspectral imaging to transform ocular diagnostics, the ophthalmology sector is predicted to grow profitably. Medical hyperspectral imaging in ophthalmology provides comprehensive insights into the retinal tissue, allowing for the accurate diagnosis of a variety of eye disorders, such as age-related macular degeneration and diabetic retinopathy. Moreover, the technology's capacity to extract spectral information from ocular tissues helps in the early diagnosis of abnormalities and offers useful information for customized therapies.
Owing to advancements in healthcare and growing technological usage, the Asia-Pacific region held the largest share. Modern medical imaging technologies are in high demand due to the region's expanding population and rising investments in healthcare infrastructure. The capacity of hyperspectral imaging to offer extensive spectral information for improved diagnosis of illnesses and surgical accuracy is in accordance with the region's increasing focus on cutting-edge medical technology. In addition, the prevalence of chronic illnesses like cancer and cardiovascular disorders has increased the demand for cutting-edge diagnostic tools, with hyperspectral imaging being offered as a revolutionary treatment.
Asia Pacific region is expected to hold lucrative growth due to government initiatives in nations like China, India, and Japan that support healthcare infrastructure and research abilities. Technological innovation is continuously driven in the region by a robust research community and collaborations between academic institutions and industry participants. Furthermore, widespread acceptance has been fueled by rising expertise among medical professionals of the benefits of hyperspectral imaging in a wide range of medical applications, such as ophthalmology, dermatology, and oncology.
Some of the key players in Medical Hyperspectral Imaging market include Applied Spectral Imaging Inc, Bayspec Inc, Cubert GmbH, HyVista Corporation Pty Ltd, Inno-Spec GmbH, ITRES Research Limited, Norsk Elektro Optikk AS, Photonics Science Co, Resonon, Inc, Si-Ware Systems, Specim Spectral Imaging Ltd., Surface Optics Corporation and Tetracam Inc.
In July 2022, Headwall Photonics announced the acquisition of Holographix LLC to expand its manufacturing capabilities to address future growth.
In June 2022, Resonon Inc. announced the launch of Pika IR-L and IR-L+ hyperspectral cameras (925 - 1700 nm).